![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/23/2917114/0/en/Reunion-Neuroscience-Inc-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-RE104-for-the-Treatment-of-Postpartum-Depression.html
https://www.globenewswire.com/news-release/2024/05/20/2884773/0/en/Reunion-Neuroscience-Announces-Publication-of-Results-from-Early-Preclinical-Studies-Demonstrating-the-Potential-of-RE104-for-Development-in-Depressive-Disorders.html
https://www.globenewswire.com/news-release/2024/05/02/2873978/0/en/Reunion-Neuroscience-Inc-Announces-103-Million-Series-A-Financing-Co-Led-by-MPM-BioImpact-and-Novo-Holdings.html